Treatment of Papillary Thyroid Carcinoma ≤4 cm Limited to the Thyroid (cT1–cT2, cN0, cM0)

This page addresses the treatment approach for patients with papillary thyroid carcinoma confined to the thyroid gland, measuring ≤4 cm, with no regional lymph node involvement and no distant spread.

Clinical scenario Papillary thyroid carcinoma measuring ≤4 cm, without gross extrathyroidal extension (cT1–cT2), no regional cervical lymph node metastasis (cN0), and no distant metastasis (cM0). Initial surgical management — and whether further intervention is warranted — depends on tumour size within this range and on findings that may emerge during or after the initial procedure.

Treatment Approach

When further surgical intervention is indicated following initial resection, the structured approach involves a conversion procedure targeting the remaining thyroid tissue to address persistent primary malignancy and enable subsequent management steps. The full eligibility criteria, sequencing, and decision points are in the complete protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1177/10507256251363120

When resection is performed for patients with thyroid cancer ≤2 cm without gross extra-thyroidal extension (cT1) and without metastases (cN0M0), the initial surgical procedure should be a thyroid lobectomy unless there are bilateral cancers or other indications to remove the contralateral lobe.

For patients with low risk, unilateral thyroid cancer >2 and ≤4 cm (cT2N0M0), thyroid lobectomy may be the preferred initial surgical treatment due to significantly lower risk and side effects.

When thyroid lobectomy is offered as initial treatment, counsel the patient about the possibility of conversion to total thyroidectomy or need for subsequent completion thyroidectomy if higher-risk factors emerge intraoperatively or postoperatively.

Completion thyroidectomy for cancer following initial lobectomy may be considered to address persistent primary malignancy, facilitate RAI administration, and/or enhance follow-up based upon higher estimated risk of recurrence identified postoperatively, accounting for recurrent laryngeal nerve function.

View source ↗